HW
SRDX

Hancock Whitney’s Surmodics SRDX Stock Holding History

Hancock Whitney’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,891
Closed -$269K – 660
2022
Q4 		$269K Sell
7,891
-2,578
-25% -$86.4K 0.01% 555
2022
Q3 		$318K Buy
10,469
+3,385
+48% +$116K 0.01% 513
2022
Q2 		$264K Sell
7,084
-213
-3% -$8.26K 0.01% 577
2022
Q1 		$331K Sell
7,297
-5,774
-44% -$253K 0.01% 572
2021
Q4 		$629K Sell
13,071
-265
-2% -$13.3K 0.02% 432
2021
Q3 		$741K Sell
13,336
-1,114
-8% -$61.9K 0.03% 373
2021
Q2 		$784K Sell
14,450
-20
-0.1% -$1.1K 0.03% 450
2021
Q1 		$811K Buy
14,470
+149
+1% +$7.43K 0.03% 445
2020
Q4 		$623K Sell
14,321
-9,342
-39% -$368K 0.02% 477
2020
Q3 		$921K Buy
23,663
+10,572
+81% +$464K 0.03% 383
2020
Q2 		$566K Buy
+13,091
New +$496K 0.02% 487

Other funds holding SRDX

TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Hancock Whitney's SRDX Position: Q1 2023 in Review

Hancock Whitney sold out of Surmodics (SRDX) in Q1 2023, closing a stake of 7,891 shares — an estimated $269K sold.

Hancock Whitney first reported a position in SRDX in Q2 2020 and held it in 11 quarters. The position peaked at $921K in Q3 2020. 119 funds tracked by Wall St. Rank hold SRDX as of Q1 2023.

  • Hancock Whitney reported no remaining Surmodics position as of Q1 2023 after selling out during the quarter.
  • Hancock Whitney sold 7,891 Surmodics shares in Q1 2023, an estimated $269K.
  • Hancock Whitney first reported a position in Surmodics in Q2 2020 and held it in 11 quarters.
  • Hancock Whitney's Surmodics position peaked at $921K in Q3 2020.
  • 119 funds tracked by Wall St. Rank held Surmodics as of Q1 2023.

Based on Hancock Whitney's 13F filing for Q1 2023, filed 15 May 2023.